dc.description.abstract | Sensing methodologies are indispensable for detecting and quantifying physical, chemical,
and biological parameters with precision, especially for biomedical applications.
These techniques enable early disease detection, real-time physiological monitoring, and
personalized healthcare, significantly improving patient outcomes. Among these, photoacoustic
sensing, which converts optical energy into ultrasound signals could enable
deep tissue biomolecular sensing.
This thesis presents an innovative approach that combines polarized light, photoacoustic
sensing, and microfluidic technologies for biomolecular detection, focusing on
chiral biomolecules that are optically active. Near Infra-red-II (NIR-II) wavelengths
(1000-1700nm) are known for less optical scattering compared to visible wavelength
regimes and offers deep tissue penetration. Interference from scattering effects can be
avoided while using NIR-II wavelengths. Integration of polarization and photoacoustics
offered the advantages of detecting from deeper tissues with less scattering interference
that will normally arises from pure optical methods.
Chiral molecule sensing is typically performed using techniques like chromatography,
electrophoresis, enzymatic assays, mass spectrometry, and chiroptical methods. While
polarimetry allows for in-vivo sensing up to 1 mm depth using UV-visible light, it is
limited by dominant light scattering beyond this depth. We propose that photoacoustic
sensing in the Near-Infrared (NIR)-II window can enable deep tissue sensing as acoustic
waves scatter less than light. To achieve this, we developed a Photoacoustic Polarization
Enhanced Optical Rotation Sensing (PAPEORS) system, capable of estimating optical
rotation from photoacoustic signals and correlating it with chiral molecular concentration for depths up to 3.5 mm. We also analyzed the optical rotation estimation using
different polarization illumination’s with photoacoustic sensing. Non-invasive potential
of the system was also demonstrated with preliminary in-vivo experiments. Our study
concluded that PAPEORS holds promise for in-vivo sensing and easy miniaturization
utilizing single wavelength.
Non-invasive glucose sensing presents significant challenges due to the high scattering
and complex optical properties of biological tissues. To address this, we explored evaluation
of depth-dependent photoacoustic signals at the the Near-Infrared (NIR)-II window,
leveraging different polarization states—vertical, 45° linear, and circular—alongside
Monte Carlo simulations. This approach revealed an optimal sensing depth of 3–3.2
mm, where maximum optical rotation and strong linear correlations with glucose concentration
was observed. These findings establish a foundation for precise, non-invasive
glucose detection while also providing a calibration framework applicable to other chiral
biomolecules.
To further understand the wavelength-dependent behaviour of optical rotation, we
extended our investigation to Photoacoustic Circular Dichroism (PACD) spectroscopy in
the NIR-II range (1400–1600 nm) for D-glucose. By analysing optical rotation, circular
dichroism, and optical rotary dispersion, we demonstrated the system’s ability to probe
the chiral nature and optical activity of glucose molecules. The differential absorption
of left- and right-circularly polarized light in serum samples validated PACD as a viable
tool for biomolecular characterization.
Building on these insights, we developed an innovative opto-acoustic microfluidic
glucose sensing system that integrated polarized light incidence with photoacoustic detection.
Designed to mimic blood vessel dimensions, this microfluidic platform enabled
precise optical rotation measurements in serum-like and human blood samples. Proofof-
concept studies involving diabetic and healthy volunteers achieved an 88% prediction
accuracy, highlighting the potential of this system for real-time, non-invasive glucose
monitoring.
In summary, the thesis introduced advanced photoacoustic sensing methodologies that combine polarized light, optical activity, and microfluidic integration for deeptissue
biomolecular detection. These innovations would pave the way for real-time, costeffective,
and highly accurate diagnostic tools, offering new possibilities for personalized
healthcare and improved disease management. | en_US |